• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Cepheid

NASDAQ:CPHD

$38.47 $0.38 (1.00%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

FDA Nod for Cepheid's Infinity-80 - Analyst Blog

5/25/2012 by NASDAQ

FDA Nod for Cepheid's Infinity-80 - Analyst Blog

5/25/2012 by Zacks Investment Research

Leerinks' life science tools and medical devices analysts hold a conference call

5/24/2012 by Theflyonthewall.com

Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Rolling Out Another Assay

5/24/2012 by StreetInsider.com

Cepheid (CPHD): FDA Clears Genexpert Infinity-80 System For Initial Use With Xpert Flu Assay

5/24/2012 by iStockAnalyst

Cepheid (CPHD) Receives FDA Approval for GeneXpert Infinity-80 System

5/24/2012 by StreetInsider.com

Cepheid receives FDA clearance for GeneXpert

5/24/2012 by Theflyonthewall.com

Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay

5/24/2012 by PR Newswire

Cepheid announces European release of Xpert CT/NG and Xpert CT

5/23/2012 by Theflyonthewall.com

Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae

5/23/2012 by PR Newswire

Perception, Opportunity in Volatility - Research & Analysis on Agilent Technologies Inc. and Cepheid

5/21/2012 by Marketwire

Cepheid has a conference call hosted by JP Morgan

5/17/2012 by Theflyonthewall.com

Cepheid (CPHD) Upgraded To 'Buy' By UBS Securities, PT Lifted To $45

5/15/2012 by iStockAnalyst

UPDATE: UBS Upgrades Cepheid (CPHD) to Buy; Recent Dip Offers Opportunity

5/15/2012 by StreetInsider.com

Cepheid upgraded to Buy from Neutral at UBS

5/15/2012 by Theflyonthewall.com

Cepheid Back to Neutral - Analyst Blog

5/14/2012 by NASDAQ

Cepheid Back to Neutral - Analyst Blog

5/14/2012 by Zacks Investment Research

Cepheid Back to Neutral

5/14/2012 by Zacks Equity Research Analyst Blog

Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year

5/1/2012 by StockWatch

Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year

5/1/2012 by PR Newswire

Cepheid to Webcast Upcoming Financial Presentations

4/26/2012 by PR Newswire

GARP Research Of In Defense on Cepheid (CPHD); Franchise Remains Solid Plus Progress In Pipeline

4/25/2012 by StreetInsider.com

Cepheid Punished For Unwelcome Variability

4/20/2012 by Seeking Alpha

Tempur-Pedic, Riverbed And Cepheid Stocks Plummet On Downbeat Outlook

4/20/2012 by iStockAnalyst

Cepheid Incurs Loss as Costs Rise - Analyst Blog

4/20/2012 by NASDAQ

Cepheid breaks below its 10-day MA, support is at $37.55

4/20/2012 by Theflyonthewall.com

Cepheid Incurs Loss as Costs Rise - Analyst Blog

4/20/2012 by Zacks Investment Research

Cepheid recommended on weakness at Canaccord

4/20/2012 by Theflyonthewall.com

Cepheid shares should be bought on any weakness, says RBC Capital

4/20/2012 by Theflyonthewall.com

Cepheid weakness a buying opportunity, says William Blair

4/20/2012 by Theflyonthewall.com

After-market Movers For April 19 (MSFT, COF, AMD, SNDK, RVBD, EXTR, TPX, CPHD)

4/19/2012 by RTTNews

Cepheid reports Q1 EPS (2c), consensus (2c)

4/19/2012 by Theflyonthewall.com

Cepheid Reports 2012 First Quarter Results

4/19/2012 by PR Newswire

Cepheid Q1 Estimates Soft, But Outlook For Year Good

4/18/2012 by Investor's Business Daily

Global Gene Amplification Technologies Industry

4/16/2012 by PR Newswire

April's Earnings Report Could Be A Shot In The Arm For Cepheid

4/13/2012 by Forbes

UNC Team Wins NIH Grant to Study Treatment Outcomes of TB Patients Diagnosed with Cepheid Test

4/12/2012 by GenomeWeb

Zacks Releases Four Powerful ''Buy'' Stocks: Cepheid, Eaton Vance, ULTA Beauty and Agrium

4/12/2012 by PR Newswire

Zacks Releases Four Powerful ''Buy'' Stocks: Cepheid, Eaton Vance, ULTA Beauty and Agrium - Press Releases

4/12/2012 by NASDAQ

Zacks Releases Four Powerful ''Buy'' Stocks: Cepheid, Eaton Vance, ULTA Beauty and Agrium - Press Releases

4/12/2012 by Zacks Investment Research
See More Articles...